BioSpace News Archive

Bovie Medical (NYSEMKT:BVX), a medical technology company and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion™ Cosmetic Technology brand in the cosmetic surgery market, today announced that financial results for the third quarter of fiscal year 2018 will be released after the market closes on Thursday, November 1.

Retrophin, Inc. today announced that presentations highlighting the design of the ongoing pivotal Phase 3 FORT Study of fosmetpantotenate for the treatment of pantothenate kinase-associated neurodegeneration (PKAN), the patient and caregiver experience with PKAN, and the diagnostic pathway and clinical experience of patients with PKAN, will be presented by the Company and its collaborators at upcoming medical congresses in October.

AmerisourceBergen Corporation today announced that it plans to release its results for the Fourth Quarter Fiscal 2018 on Tuesday, November 6, 2018, prior to the opening of trading on the New York Stock Exchange.

Event to be Webcast Live on Thursday, October 11, 2018, at 8:30 a.m. ET

New studies highlight health and economic benefits of adjuvanted trivalent influenza vaccine amongst two at-risk populations - 65 years+ and young children

Birner Dental Management, Inc. Shareholders to Receive Total Cash Consideration of up to $10.75 per share

Spring Bank Pharmaceuticals, Inc. today announced it will present inarigivir soproxil (inarigivir) data in both an oral and poster presentation at the American Association for the Study of Liver Disease (AASLD) Annual Meeting (The Liver Meeting®) being held on November 9-13 in San Francisco, CA.

Addiction Treatment Leader Advocates For Further Action To Ensure Quality Addiction Treatment

Biopsy of fourth patient showed robust micro-dystrophin expression as measured by Western blot and immunohistochemistry

Antibe Therapeutics Inc. announces that it has granted restricted share units (“RSUs”) pursuant to the Company’s RSU plan that was adopted at the most recent annual shareholder’s meeting on June 25, 2018.